daclatasvir

DCGI Rejects Mylan’s Request to Waive Phase 3 Trials for COVID-19 Drug

In India, Stakeholders Drive Down Drug Prices for the Benefit of All

Credit: rico_gustav/Flickr, CC BY 2.0 (patent)

All You Need to Know: September’s Crucial Verdict on the Sofosbuvir Patent Saga